Sponsor Pipeline

ML Bio Solutions, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05775848 Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb… Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) Active, Not Recruiting
NCT07678775 Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) Active, Not Recruiting
Phase 2
NCT04800874 Study of BBP-418 in Patients With LGMD2I LGMD2I Active, Not Recruiting
Get alerts when ML Bio Solutions, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free